Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

SHEZF

Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

USD

Set alert

Price alert · SHEZF

All alert types
0.47 USD 0.00 0.00%
As of Oct 29, 2026
0.7206 Day range 0.7206
0.4696 52-week range 0.7206
YTD
0.00%
1 year
0.00%
Open
0.7206
Prev close
0.4696
Mkt cap
689.04M
Vol
25
Avg vol
0
EPS
-0.02
P/E
0.00
More statistics
Low
0.7206
High
0.7206

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for SHEZF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

1.81 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

8 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 13.7×
FY 2016: 32.3×FY 2017: 88.1×FY 2018: 20.9×FY 2019: 12.2×FY 2020: 12.8×FY 2021: 59.6×FY 2022: 9.9×FY 2023: -9.6×FY 2024: 7.8×FY 2025: 13.7×
FY 2016 5y median 9.9× FY 2025
P/S 0.9×
FY 2016: 5.7×FY 2017: 4.5×FY 2018: 2.7×FY 2019: 2.8×FY 2020: 2.5×FY 2021: 2.2×FY 2022: 1.0×FY 2023: 1.4×FY 2024: 1.0×FY 2025: 0.9×
FY 2016 5y median 1.0× FY 2025
P/B 0.4×
FY 2016: 1.6×FY 2017: 1.6×FY 2018: 2.1×FY 2019: 1.8×FY 2020: 1.1×FY 2021: 1.2×FY 2022: 0.6×FY 2023: 0.6×FY 2024: 0.4×FY 2025: 0.4×
FY 2016 5y median 0.6× FY 2025
P/FCF 3.0×
FY 2016: -964×FY 2017: -12.3×FY 2018: 96.2×FY 2019: -21.9×FY 2020: -75.1×FY 2021: -69.7×FY 2022: -7.4×FY 2023: -161×FY 2024: 2.5×FY 2025: 3.0×
FY 2016 5y median -7.4× FY 2025
EV/EBITDA 6.6×
FY 2016: 17.2×FY 2017: 30.4×FY 2018: 13.8×FY 2019: 9.8×FY 2020: 8.6×FY 2021: 23.0×FY 2022: 8.5×FY 2023: -28.5×FY 2024: 5.3×FY 2025: 6.6×
FY 2016 5y median 6.6× FY 2025
EV/Sales 1.0×
FY 2016: 5.4×FY 2017: 5.0×FY 2018: 3.2×FY 2019: 3.9×FY 2020: 3.0×FY 2021: 2.6×FY 2022: 1.6×FY 2023: 1.7×FY 2024: 1.2×FY 2025: 1.0×
FY 2016 5y median 1.6× FY 2025
FCF Yield 33.0%
FY 2016: -0.1%FY 2017: -8.1%FY 2018: 1.0%FY 2019: -4.6%FY 2020: -1.3%FY 2021: -1.4%FY 2022: -13.4%FY 2023: -0.6%FY 2024: 39.6%FY 2025: 33.0%
FY 2016 5y median -0.6% FY 2025

Profitability

Gross Margin 31.8%
FY 2016: 32.0%FY 2017: 24.0%FY 2018: 40.1%FY 2019: 37.3%FY 2020: 39.2%FY 2021: 31.9%FY 2022: 32.6%FY 2023: 17.4%FY 2024: 33.3%FY 2025: 31.8%
FY 2016 5y median 31.9% FY 2025
Operating Margin 11.6%
FY 2016: 19.3%FY 2017: -0.3%FY 2018: 15.0%FY 2019: 28.4%FY 2020: 24.9%FY 2021: 3.6%FY 2022: 11.6%FY 2023: -15.8%FY 2024: 14.0%FY 2025: 11.6%
FY 2016 5y median 11.6% FY 2025
Net Margin 6.4%
FY 2016: 17.6%FY 2017: 4.9%FY 2018: 12.8%FY 2019: 22.9%FY 2020: 19.2%FY 2021: 3.8%FY 2022: 10.2%FY 2023: -14.4%FY 2024: 12.2%FY 2025: 6.4%
FY 2016 5y median 6.4% FY 2025
ROE 2.9%
FY 2016: 5.0%FY 2017: 1.7%FY 2018: 10.2%FY 2019: 14.4%FY 2020: 8.9%FY 2021: 2.1%FY 2022: 5.9%FY 2023: -6.6%FY 2024: 5.3%FY 2025: 2.9%
FY 2016 5y median 2.9% FY 2025
ROIC 3.7%
FY 2016: 3.1%FY 2017: -0.1%FY 2018: 5.0%FY 2019: 7.9%FY 2020: 5.9%FY 2021: 1.4%FY 2022: 3.7%FY 2023: -4.6%FY 2024: 4.1%FY 2025: 3.7%
FY 2016 5y median 3.7% FY 2025
ROA 2.1%
FY 2016: 3.1%FY 2017: 1.0%FY 2018: 4.5%FY 2019: 7.0%FY 2020: 5.4%FY 2021: 1.3%FY 2022: 3.5%FY 2023: -4.1%FY 2024: 3.7%FY 2025: 2.1%
FY 2016 5y median 2.1% FY 2025

Growth (YoY)

Revenue 3.8%
FY 2016: -1.4%FY 2017: 18.1%FY 2018: 80.3%FY 2019: -4.0%FY 2020: 15.3%FY 2021: 19.4%FY 2022: 12.5%FY 2023: -23.9%FY 2024: -3.0%FY 2025: 3.8%
FY 2016 FY 2025
Operating Income -14.2%
FY 2016: -32.3%FY 2017: -101.7%FY 2018: 9843.2%FY 2019: 82.3%FY 2020: 1.2%FY 2021: -82.9%FY 2022: 264.3%FY 2023: -203.9%FY 2024: 186.1%FY 2025: -14.2%
FY 2016 FY 2025
EPS (diluted) -45.5%
FY 2016: -30.4%FY 2017: -65.6%FY 2018: 345.5%FY 2019: 73.5%FY 2020: -10.6%FY 2021: -78.9%FY 2022: 212.5%FY 2023: -206.0%FY 2024: 183.0%FY 2025: -45.5%
FY 2016 FY 2025
Free Cash Flow -20.1%
FY 2016: -101.9%FY 2017: -7202.8%FY 2018: 113.5%FY 2019: -543.8%FY 2020: 70.3%FY 2021: -14.4%FY 2022: -388.3%FY 2023: 95.2%FY 2024: 4367.6%FY 2025: -20.1%
FY 2016 FY 2025

Financial Health

Current Ratio 2.3×
FY 2016: 3.2×FY 2017: 1.9×FY 2018: 1.2×FY 2019: 1.2×FY 2020: 2.5×FY 2021: 2.2×FY 2022: 2.2×FY 2023: 2.1×FY 2024: 2.6×FY 2025: 2.3×
FY 2016 5y median 2.2× FY 2025
Quick Ratio 1.2×
FY 2016: 3.0×FY 2017: 1.6×FY 2018: 0.9×FY 2019: 0.7×FY 2020: 1.6×FY 2021: 1.3×FY 2022: 1.0×FY 2023: 0.8×FY 2024: 1.1×FY 2025: 1.2×
FY 2016 5y median 1.1× FY 2025
Debt / Equity 0.2×
FY 2016: 0.5×FY 2017: 0.6×FY 2018: 0.8×FY 2019: 0.9×FY 2020: 0.5×FY 2021: 0.5×FY 2022: 0.5×FY 2023: 0.3×FY 2024: 0.2×FY 2025: 0.2×
FY 2016 5y median 0.3× FY 2025
Net Debt / EBITDA 0.9×
FY 2016: -0.9×FY 2017: 2.8×FY 2018: 2.5×FY 2019: 2.7×FY 2020: 1.6×FY 2021: 3.7×FY 2022: 3.2×FY 2023: -5.8×FY 2024: 1.1×FY 2025: 0.9×
FY 2016 5y median 1.1× FY 2025
Interest Coverage 8.9×
FY 2016: 5.5×FY 2017: -0.1×FY 2018: 3.6×FY 2019: 5.1×FY 2020: 5.4×FY 2021: 1.1×FY 2022: 3.5×FY 2023: -3.9×FY 2024: 5.3×FY 2025: 8.9×
FY 2016 5y median 3.5× FY 2025

Dividends

Dividend Yield 8.9%
FY 2016: 4.2%FY 2017: 3.8%FY 2018: 2.0%FY 2019: 2.6%FY 2020: 1.7%FY 2021: 1.6%FY 2022: 0.7%FY 2023: 5.7%FY 2024: 3.2%FY 2025: 8.9%
FY 2016 5y median 3.2% FY 2025
Payout Ratio 123.3%
FY 2016: 136.4%FY 2017: 347.9%FY 2018: 41.4%FY 2019: 32.3%FY 2020: 21.9%FY 2021: 91.4%FY 2022: 7.1%FY 2023: -54.4%FY 2024: 24.7%FY 2025: 123.3%
FY 2016 5y median 24.7% FY 2025

Annual · latest fiscal year ends 2025-12-31